Pharmafile Logo
Pharmafocus logo
Advanced Search
janssen_latest_logo_on_sign

NICE rejects Janssen’s esketamine nasal spray Spravato for treatment-resistant depression

January 28, 2020
Manufacturing and Production, Sales and Marketing Janssen, NHS, NICE, Spravato, depression

Janssen’s Spravato (esketamine) nasal spray, derived from the party drug ketamine, has been turned down by NICE for NHS use …

News

“Pharma Bro” Martin Shkreli charged by FTC for price fixing Daraprim

January 28, 2020
Manufacturing and Production FTC, Martin Shkreli, New York Attorney General, Pharma Bro

Martin Shkreli, also known as the “Pharma Bro”, has been charged by the Federal Trade Commission for price fixing. The …

News
mrt_big

FDA approves MS drug for human trials

January 27, 2020
Sales and Marketing MS, MS symptoms, MS treatment, Neuro, neurology

A drug that can make it easier to diagnose Multiple Sclerosis (MS) has been approved for its first human trials …

News
lynn_taylor_updated_headshot_web

Realising the potential of greater collaboration for women living with cancer

January 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Merck KGaA, feature, pharma, women

Following the launch of a new global report, ‘Supporting women with cancer’, Lynn Talyroe, Senior Vice President, Head of Healthcare …

Feature

NICE refuses Novo Nordisk’s obesity therapy Saxenda for NHS use

January 27, 2020
Sales and Marketing NHS, NICE, Novo Nordisk, UK, obesity, saxenda

NICE, the drug watchdog for England and Wales, has revealed that it has chosen not to recommend Novo Nordisk’s Saxenda …

News
woman-wearing-mouth-mask

Chinese coronavirus spread is accelerating as Xi Jinping labels it a “grave situation”

January 27, 2020
Sales and Marketing Chinese Coronavrius, MARS, Sars, Viral pnemonia, respiration

The spread of the Chinese coronavirus is accelerating, as multiple countries set up checks and tests to contain the virus. …

News

FDA greenlights its first therapy for advanced epithelioid sarcoma population

January 27, 2020
Sales and Marketing Cancer, Epizyme, FDA, Tazverik, pharma

The FDA has revealed the approval of its first therapy for the treatment of metastatic or locally advanced epithelioid sarcoma, …

News
920x920

Judge overseeing Purdue Pharma bankruptcy approves $1.3 million bonus for CEO

January 27, 2020
Sales and Marketing Election 2020, OxyContin, Purdue Pharma, US Presidential Race, fentanyl, opioid crisis

Purdue Pharma’s CEO Craig Landau can receive a $1.3 million bonus, ruled a judge. Judge Robert Drain said the company …

News
top_10_image_43

Top Ten most popular articles on Pharmafile.com this week

January 24, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared …

News
janssen_latest_logo_on_sign_closer

European Commission expands Stelara for paediatric moderate to severe plaque psoriasis

January 24, 2020
Research and Development Europe, Janssen, Stelara, pharma

Janssen’s Stelara (ustekinumab) has seen its label expanded in Europe to include the treatment of moderate to severe plaque psoriasis …

News
chandler-01

FDA puts MDMA therapy for PTSD on its Expanded Access program

January 24, 2020
Medical Communications Expanded Access, MAPS, MDMA, PTSD, pharmaceuticals, psychedelics, war

The FDA has made MDMA treatment for PTSD more accessible by putting it on the Expanded Access program. 10 sites …

News

Roche’s Tecentriq falls short as an adjuvant monotherapy in muscle-invasive urothelial cancer

January 24, 2020
Medical Communications, Sales and Marketing Cancer, Roche, pharma, tecentriq, trial failure

Roche has released an update on the development of its immunology Tecentriq (atezolizumab), making it known that the drug failed …

News
woman-wearing-mouth-mask

UK tests 14 people for Chinese coronavirus

January 24, 2020
Medical Communications Chinese Coronavirus, NHS, Public Health England, Viral outbreaks, Viral pnemonia, coronavirus, epidemic

14 people in the UK have been tested for the Chinese coronavirus, according to Public Health England (PHE). In Scotland, …

News
shutterstock_92671375

Former Insys sales exec sentenced to a year in prison for offering lap dances to encourage fentanyl spray prescriptions

January 23, 2020
Medical Communications, Sales and Marketing insys, pharma

A sales executive at the disgraced and bankrupted firm Insys who was accused of offering lap dances in order to …

News
shutterstock_95714119

Oxford Immunotec to supply TB diagnostic tests to china to aid in coronavirus crisis

January 23, 2020
Medical Communications, Sales and Marketing China, Oxford Immunotec Global, Wuhan, coronavirus, pharma

As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the …

News

NICE declines to recommend Astellas’ Xospata in rlapsed/refractory FLT3+ acute myeloid leukaemia

January 23, 2020
Sales and Marketing Astellas, NHS, NICE, UK, Xospata, acute myeloid leukaemia

The latest in a series of rejections over the past week, NICE has revealed that it has knocked back the …

News
roche__tree

Roche’s risdiplam hits main goal in infants with spinal muscular atrophy

January 23, 2020
Research and Development Roche, pharma, risdiplam, spinal muscular atrophy

Roche has announced the success of its survival motor neuron-2 (SMN2) splicing modifier risdiplam in a new trial investigating its …

News

China approves Roche cancer drug Kadcyla

January 22, 2020
Business Services China, Roche, breast cancer, cancer treatment, oncology

China has approved the import of Roche’s drug for breast cancer, just after it recently won expanded approval in the …

News
5204602349_c87b204860_b

FDA fast-tracks GSK’s multiple myeloma drug after priority review

January 22, 2020
Research and Development BCMA, FDA, GSK, Phase 2 Trials, Phase Trials, multiple myeloma, myeloma

The FDA has fast tracked GlaxoSmithKline (GSK) antibody drug conjugate (ADC) belantamab mafodotin, for the treatment of patients with refractory …

News
fda2outsideweb

Horizon’s Tepezza becomes first and only FDA-approved drug for thyroid eye disorder

January 22, 2020
Research and Development FDA, Horizon Therapeutics, Tepezza, pharma

Horizon Therapeutics has announced that its IGF-1R inhibitor Tepezza (teprotumumab-trbw) has become the first and only therapy approved by the …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026